Lv6
1847 积分 2022-02-12 加入
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2天前
已完结
Single-cell spatial transcriptomics of tertiary lymphoid organ-like structures in human atherosclerotic plaques
3天前
已完结
Function Blocking Antibodies to Neuropilin-1 Generated from a Designed Human Synthetic Antibody Phage Library
4天前
已完结
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
4天前
已完结
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
8天前
已完结
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer
9天前
已完结
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma
11天前
已完结
Synergistic effects of CTLA‐4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo
11天前
已完结
Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
11天前
已完结
A phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma
11天前
已关闭
皖公网安备34019202002308
